Severe thalassaemia intermedia: Clinical problems in the absence of hypertransfusion

Blood Reviews

Volumn 12, Issue 3, 1998, Pages 163-170

  Mohamed, N ^a   Jackson, N ^a,b  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHELATING AGENT; DEFEROXAMINE; IRON CHELATE;

AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD TRANSFUSION; BONE MALFORMATION; DRUG COST; EXTRAMEDULLARY HEMATOPOIESIS; FRACTURE; HUMAN; LEG ULCER; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SURVIVAL; THALASSEMIA;

EID: 0031663924     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(98)90014-5     Document Type: Article

References (86)

1. Weatherall DJ. The molecular basis for phenotypic diversity of genetic disease. Ann N Y Acad Sci 1995; 758: 245-260.
2. Piomelli S. The management of patients with Cooley's anemia: transfusions and splenectomy. Semin Hematol 1995; 32: 262-268.
3. Roberts I. Current status of allogeneic transplantation for haemoglobinopathies. Br J Haematol 1997; 98: 1-7.
4. Jensen CE, Tuck SM, Wonke B. Fertility in beta thalassaemia major: a report of 16 pregnancies, preconceptual evaluation and a review of the literature. Br J Obstet Gynaecol 1995; 102: 625-629.
5. Rund D, Rachmilewitz E. Thalassemia major 1995: older patients, new therapies. Blood Rev 1995; 9: 25-32.
6. Cao A, Galanello R, Rosatelli MC. Genotype-phenotype correlations in β-thalassemias. Blood Rev 1994; 8: 1-12.
7. Piankijagum A, Palungwachira P, Lohkoomgunpai A. Beta thalassemia, hemoglobin E and hemoglobin H disease. Clinical analysis 1964-1976. J Med Assoc Thai 1978; 61: 50-59.
8. Wasi P, Na-Nakorn S, Pootrakul S, Sookanek M, Disthasongchan P, Panich V, Pornpatkul M. Alpha- and beta-thalassemia in Thailand. Ann N Y Acad Sci 1969; 165: 60-82.
9. Wasi P. Thalassaemia: clinical aspects and screening. In: McArthur JR, Lee SH, Wong JEL, Ong YW (eds). Haematology 1996. Education programme of the 26th Congress of the International Society of Haematology, Singapore. 1996; 226-233.
10. Kattamis CA, Kattamis AC. Management of thalassemias: growth and development, hormone substitution, vitamin supplementation, and vaccination. Semin Hematol 1995; 32: 269-279.
11. Vecchio C, Derchi G. Management of cardiac complications in patients with thalassemia major. Semin Hematol 1995; 32: 288-296.
12. Johanson NA. Musculoskeletal problems in hemoglobinopathy. Orthop Clin North Am 1990; 21: 191-198.
13. Caffey J. Cooley's anemia: a review of the roentgenographic findings in the skeleton. AJR 1957; 78: 381-391.
14. Giardina PJ, Simmons BH, Gertner J et al. Osteopenia in beta-thalassemia as measured by photon absorptiometry. Transactions of the 30th Annual Meeting of the American Society of Hematology, 1988.
15. Ashbell MB. Orthodontic aspects of Cooley's anemia. Ann N Y Acad Sci 1964; 119: 662-663.
16. Sheikha A, Kameswaran M, Okafor BC, al-Saigh AA. Otological manifestations of thalassaemia intermedia: evidence of temporal bone involvement and report of a unique choleasteatoma-like lesion. J Laryngol Otol 1992; 106: 316-321.
17. Oberklaid F, Seshadri R. Hypoparathyroidism and other endocrine dysfunction complicating thalassaemia major. Med J Aust 1975; 1: 304-306.
18. Bothwell TH, Charlton RW. Dietary iron overload. In: Kief H (ed.) Iron metabolism and its disorders. Amsterdam; Exerta Medica 1975; 221-229.
19. Finsterbush A, Farber I, Mogle P, Goldfarb A. Fracture patterns in thalassemia. Clin Orthop 1985; 192: 132-136.
20. Exarchou E, Politou C, Vretou E, Pasparakis D, Madessis G, Caramerou A. Fractures and epiphyseal deformities in Beta-thalassemia. Clin Orthop 1984; 189: 229-233.
21. Gratwick GM, Bullough PG, Bohne WH, Markenson AL, Peterson CM. Thalassemic osteoarthropathy. Ann Intern Med 1978; 88: 494-501.
22. Dines DM, Canale VC, Arnold WD. Fractures in thalassemia. J Bone Joint Surg Am 1976; 58-A: 662-666.
23. Kattamis C, Touliatos N, Haidas S, Matsaniotis N. Growth of children with thalassaemia: effect of different transfusion regimes. Arch Dis Child 1970; 45: 502-509.
24. Dore F, Cianciulli P, Rovasio S et al. Incidence and clinical study of ectopic erythropoiesis in adult patients with thalassemia intermedia. Ann Ital Med Int 1992; 7: 137-140.
25. Sorsdahl OS, Taylor PE, Noyes WD. Extramedullary hematopoiesis, mediastinal masses and spinal cord compression. JAMA 1964; 189: 343-347.
26. Lee AC, Chiu W, Tai KS, Wong V, Peh WC, Lau YL. Hypertransfusion for spinal cord compression secondary to extramedullary hematopoiesis. Pediatr Hematol Oncol 1996; 13: 89-94.
27. Fucharoen S, Suthipongchai S, Poungvarin N, Ladpli S, Sonakul D, Wasi P. Intracranial extramedullary hematopoiesis inducing epilepsy in a patient with beta-thalassemia-hemoglobin E. Arch Intern Med 1985; 145: 739-742.
28. Sonakul D, Pacharee P, Thakerngol K. Pathological findings in 76 autopsy cases of thalassemia. Birth Defects 1987; 23(5A): 157-176.
29. Vatanavicharn S, Anuvatanakulchai M, Na-Nakorn S, Wasi P. Serum and erythrocyte folate levels in thalassaemic patients in Thailand. Scand J Haematol 1979; 22: 241-245.
30. Luhby AL, Cooperman JM, Feldman R, Ceraolo J, Herrero J, Marley JF. Folic-acid deficiency as a limiting factor in the anemias of thalassemia major. Blood 1961; 18: 786-787.
31. Weatherall DJ, Clegg JB. The thalassaemia syndromes. 3rd edition. Oxford: Blackwell Scientific Publications, 1981: 163.
32. Paik CH, Alavi L, Dunea G, Weiner L. Thalassemia and gouty arthritis. JAMA 1970; 213: 296-297.
33. Chandrcharoensin-Wilde C, Chairoongruang S, Jitnuson P, Fucharoen S, Vathanopas V. Gallstones in thalassemia. Birth Defects 1987; 23(5B): 263-267.
34. Aswapokee A, Aswapokee N, Fucharoen S, Sukroongreung S, Wasi P. Severe infection in thalassemia: a prospective study. Birth Defects 1987; 23(5A): 521-526.
35. Aswapokee N, Aswapokee P, Fucharoen S. Wasi P. A study of infective episodes in patients with β-thalassemia/HbE disease in Thailand. Birth Defects 1987; 23(5A): 513-520.
36. Fiorelli G, Sampietro M, Romano M, Albano M, Cappelini MD. Clinical features of thalassemia intermedia in Italy. Birth Defects 1987; 23(5A): 287-295.
37. Silprasert A, Laokuldilok T, Kulapongs P. Zinc deficiency in β-thalassemia children. Birth Defects 1987; 23(5A): 473-476.
38. Gupta VL, Choubey BS. RBC survival, zinc deficiency, and efficacy of zinc therapy in sickle cell disease. Birth Defects 1987; 23(5A): 477-483.
39. Aracasory A, Cardar A, Cin S et al. Effects of Zn supplementation on linear growth in beta-thalassemia (a new approach). Am J Hematol 1987; 24: 727-736.
40. Dettelbach HR, Aviado DM. Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication. J Clin Pharmacol 1985; 25: 8-26.
41. Angelides NS, Angastiniotis C, Pavlides N. Effect of pentoxifylline on treatment of lower limb ulcers in patients with thalassemia major. Angiology 1992; 43: 549-554.
42. Giardina PJ, Grady RW. Chelation therapy in β-thalassemia: the benefits and limitations of desferrioxamine. Semin Hematol 1995; 32: 304-312.
43. de Montalembert M, Girot R, Mattlinger B, Lefrère J-J. Transfusion-dependent thalassaemia: viral complications (epidemiology and follow-up). Semin Hematol 1995; 32: 280-287.
44. Spanos T, Karageorga M, Ladis V, Peristeri J, Hatziliami A, Kattamis C. Red cell alloantibodies in patients with thalassemia. Vox Sang 1990; 58: 50-55.
45. Jolly JG, Agnihotri SK, Choudury N, Gupta D. Evaluation of haemotherapy in thalassaemias (20 years of Indian experience). J Indian Med Assoc 1992; 90: 7-9.
46. Hmida S. Mojaat N, Maamar M. Bejaoui M, Mediouni M, Boukef K. Red cell alloantibodies in patients with haemoglobinopathies. Nouv Rev Fr Hematol 1994; 36: 363-366.
47. Sirchia G, Zanella A, Parravicni A, Morelati F, Rebulla P, Mesera G. Red cell alloantibodies in thalassemia major. Transfusion 1985; 25: 110-112.
48. Fongsatitkul L, Bannawat U, Sanguansermsri T, Kulapongs P. Unexpected red cell antibodies in thalassemic children. Birth Defects 1987; 23(5B): 291-293.
49. Michail-Merianou V, Pamphili-Panousopoulou L, Piperi-Lowes L, Pelegrinis E, Karaklis A. Alloimmunization to red cell antigens in thalassemia: comparative study of usual versus better-match transfusion programmes. Vox Sang 1987; 52: 95-98.
50. Kruatrachue M, Sirisinha S, Pacharee P. Chandarayingyong D, Wasi P. An association between thalassaemia and autoimmune haemolytic anaemia (AIHA). Scand J Haematol 1980; 25: 259-263.
51. Galili U, Korkesh A, Kahane I, Rachmilewitz EA. Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells. Blood 1983; 61: 1258-1264.
52. Argiolu F, Diana G, Arnone M, Batzella MG, Piran P, Cao A. High-dose immunoglobulin in the management of autoimmune hemolytic anemia complicating thalassemia major. Acta Haematol 1990; 83: 65-68.
53. Wanachiwanawin W, Pootrakul P, Fucharoen S, Piankijagum A. High-dose intravenous immunoglobulin in the management of immune hemolysis in patients with thalassemic disease: factors which determine refractoriness. Southeast Asian J Trop Med Public Health 1991; 22: 397-401.
54. Royal JE, Seeler RA. Hypertension, convulsions, and cerebral haemorrhage in sickle-cell anaemia patients after blood-transfusions. Lancet 1978; ii: 1207.
55. Wasi P, Pootrakul P, Piankijagum A, Na-Norn S, Sonakul D, Pacharee P. A syndrome of hypertension, convulsion and cerebral haemorrhage in thalassaemic patients after multiple blood-transfusions. Lancet 1978; ii: 602-604.
56. Thirawarapan SS, Snongchart N, Fucharoen S, Tanphaichitr VS, Dhorranintra B. Study of mechanisms of post-transfusion hypertension in thalassaemic patients. Southeast Asian J Trop Med Public Health 1989; 20: 471-478.
57. 0thalassemia. Am J Clin Pathol 1990; 93: 395-399.
58. Eldor A. Abnormal platelet functions in β-thalassaemia. Scand J Haematol 1978; 20: 447-452.
59. Hirsch J, Dacie JV. Persistent post splenectomy thrombocytosis and thromboembolism: a consequence of continuing anaemia. Br J Haematol 1966; 12: 44-53.
60. Sonakul D, Fucharoen S. Pulmonary thromboembolism in thalassemic patients. Southeast Asian J Trop Med Public Health 1992; 23 (Suppl 2): 25-28.
61. Sonakul D, Pacharee P, Laohapand T, Fucharoen S, Wasi P. Pulmonary artery obstruction in thalassaemia. Southeast Asian J Trop Med Public Health 1980; 11: 516-523.
62. Jackson N, Franklin IM, Hughes MA. Recurrent priapsim following splenectomy for thalassaemia intermedia. Br J Surg 1986; 73: 678.
63. Michaeli J, Mittelman M, Grisaru D, Rachmilewitz RA. Thromboembolic complications in beta-thalassemia major. Acta Haematol 1992; 87: 71-74.
64. Isarangkura P, Pintadot P, Hathirat P, Sasankul W Platelet function tests in thalassemic children. Birth Defects 1987; 23(5A): 395-401.
65. Eldor A, Lellouche F, Goldfarb A, Rachmilewitz EA, Maclouf J. In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. Blood 1991; 77: 1749-1753.
66. Eldor A, Maclouf J, Lellouche F et al. A chronic hypercoagulable state and life-long platelet activation in beta-thalassemia major. Southeast Asian J Trop Med Public Health 1993; 24(Suppl 1): 92-95.
67. Wilairat P, Kittikalayawong A. Chaicharoen S. The thalassemic red cell membrane. Southeast J Trop Med Public Health 1992; 23 Suppl 2: 74-8.
68. Isarangkura P, Chantarojanasiri T, Sudhas Na Ayutha P, et al. Studies of cardiopulmonary and platelet function in thalassemic children. Birth Defects 1987; 23:5A: 385-93.
69. Youngchaiyud P, Suthamsmai T, Fucharoen S, Udopanich V Pushpakom R, Wasi P. Lung function tests in splenectomised β-thalassemia/HbE patients. Birth Defects 1987; 23:5A: 361-70.
70. Chantarojanasiri T. Suwanjutha S, Isarangkura P, Hathirat P, Promma W, Santati S. Studies of pulmonary function and arterial blood gases in thalassemic children. Birth Defects 1987: 23:5A 355-9.
71. Fung KP, Chow OK, So SY, Yuen PM. Pulmonary function in thalassemiamajor. J Pediatr 1987; 111: 534-7.
72. Aessopos A, Stamatelos G, Skoumas V, Vassilopoulos G. Mantzourant M, Loukopoulos D. Pulmonary hypertension and right heart failure in patients with beta-thalassemia intermedia. Chest 1995; 107: 50-53.
73. Bacalo A, Kivity S, Heno N, Greif Z, Greif J, Topilsky M. Blood transfusion and lung function in children with thalassemia major. Chest 1992; 101: 362-5.
74. Bareford D, Chandler ST, Hawker RJ, Jackson N, Smith M, Boughton BJ. Splenic platelet-sequestration following routine blood transfusion is reduced by filtered/washed blood products. Br J Haematol 1987; 67: 177-180.
75. Grisaru D, Rachmilewitz EA, Mosseri M, et al. Cardiopulmonary assessment in beta-thalassemia major. Chest 1990; 98: 1138-42.
76. Fucharoen S, Youngchaiyud P, Wasi P. Hypoxaemia and the effect of aspirin in the thalassaemia. Southeast Asian J Trop Med Public Health 1981; 12: 90-93.
77. Fucharoen A, Piankijagum A, Wasi P. Deaths in β-thalassemia/HBE patients secondary to infections. Birth Defects 1987; 23(5A): 495-500.
78. Rebulla P, Mozzi F, Contino G, Locatelli E, Sirchia G. Antibody to hepatitis C virus in 1,305 Italian multiply transfused thalassaemics: a comparison of first and second generation tests. Transfus Med 1992; 2: 69-70.
79. Aswapokee N, Aswapokee P, Fucharoen S, Wasi P. A study of infective episodes in patients with β-thalassemia/HbE disease in Thailand. Birth Defects 1987; 23(5A): 513-520.
80. Aswapokee P, Aswapokee N, Fucharoen S, Sukroongreung S, Wasi P. Severe infections in thalassaemia: a prospective study. Birth Defects 1987; 23(5A): 521-526.
81. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. BMJ 1996; 312: 430-443.
82. Jackson N, Salleh MZ, Rahman ARA, Salleh MN, Win MN, Osman S. Fatal Campylobacter jejuni infection in a patient splenectomised for thalassaemia. J Clin Pathol 1997; 50: 436-437.
83. Robins-Browne RM, Rabson AR, Koornhof HJ. Generalised infection with Yersinia enterocolitica and the role of iron. Contrib Micobiol Immunol 1979; 5: 277-282.
84. Schiliro G, Romeo MA, Di Gregorio F, Sciacca A, Mutumeci S, Russo G. Infections in Cooley disease. Birth Defects 1987; 23(5A): 487-493.
85. Modell B, Berdoukas V. The clinical approach to thalassemia. New York: Grune & Stratton, 1984.
86. Cao A, Gabutti V, Galanello R et al. Management protocol for the treatment of thalassaemia patients. Cyprus: Thalassaemia International Federation, 1997.